BanuAygunMD
Pediatric Hematology & Oncology • New Hyde Park, NYPediatric Anemia and Red Blood Cell Hematology, Pediatric Platelet Disorder Hematology
Associate Chief, Hematology Section Head, Sickle Cell Disease
Dr. Aygun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
269-01 76th Avenue
New Hyde Park, NY 11040Phone+1 718-470-3460Fax+1 718-343-4642
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology, 1997 - 2000
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 1994 - 1997
Hacettepe University FOMClass of 1992
Certifications & Licensure
NY State Medical License 2000 - 2025
TN State Medical License 2007 - 2014
IL State Medical License 1999 - 2005- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease Start of enrollment: 2006 Mar 03
- The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2 Start of enrollment: 2010 May 01
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias Start of enrollment: 2014 Apr 17
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAssessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.Arlene Smaldone, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley
Pediatric Blood & Cancer. 2024-09-01 - 1 citationsHealth Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report.Amber M Yates, Banu Aygun, Rachelle Nuss, Zora R Rogers,
Pediatrics. 2024-08-01 - 1 citationsHydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Banu Aygun, Adam Lane, Luke R Smart, Luke R Smart, Brígida Santos
The Lancet. Haematology. 2024-06-01
Abstracts/Posters
- Benefit and Safety of Isovolemic Hemodilution Prior to Red Cell Exchange in Chronically Transfused Sickle Cell PatientsBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Effects of Hydroxyurea Treatment on Malaria Infections in Sub-Saharan AfricaBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Splenomegaly in Children with Sickle Cell Anemia Receiving Hydroxyurea in Sub-Saharan AfricaBanu Aygun, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
American Academy of Pediatrics Offers Guidance on Health Supervision of Children and Teens with Sickle Cell DiseaseJuly 22nd, 2024- Corticosteroids May Harm People with Sickle Cell DiseaseApril 28th, 2022
Experimental Drug Shows Early Promise Against Sickle Cell DiseaseJune 21st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
